| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.35B | +5.2% |
| R&D Expense | $52.0M | -70.6% |
| SG&A Expense | $249.7M | +9.9% |
| Operating Income | $1.49B | +385.9% |
| Interest Expense | $187.2M | -0.4% |
| Pre-tax Income | $1.70B | +639.0% |
| Income Tax | $0 | — |
| Net Income | $1.13B | +2549.5% |
| EPS (Basic) | $2.54 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $477.0M | -72.1% |
| Current Assets | $1.27B | -50.1% |
| Total Assets | $16.38B | -2.6% |
| Current Liabilities | $161.4M | -86.2% |
| Long-term Debt | $6.14B | -13.8% |
| Total Liabilities | $6.30B | -13.6% |
| Stockholders' Equity | $10.08B | +5.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.99B | +39.4% |
| Investing Cash Flow | -$2.07B | -101.4% |
| Financing Cash Flow | -$2.15B | -127.4% |
| +2440.0% |
| EPS (Diluted) | $2.53 | +2430.0% |